argenx SE (ARGX)
USD 548.93
(-0.19%)
USD 548.93
(-0.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.1 Billion USD | 190.7% |
| 2022 | 381.31 Million USD | 3086.52% |
| 2021 | -12.76 Million USD | 95.07% |
| 2020 | -258.8 Million EUR | -118.13% |
| 2019 | -118.64 Million EUR | -582.83% |
| 2018 | 24.57 Million EUR | -43.75% |
| 2017 | 43.68 Million EUR | 182.33% |
| 2016 | 15.47 Million EUR | 106.49% |
| 2015 | 7.49 Million EUR | 64.07% |
| 2014 | 4.56 Million EUR | 70.61% |
| 2013 | 2.67 Million EUR | 22.6% |
| 2012 | 2.18 Million EUR | 49.75% |
| 2011 | 1.45 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 777.66 Million USD | 130.53% |
| 2024 Q1 | 357.82 Million USD | 35.33% |
| 2023 Q2 | 246.52 Million USD | 22.77% |
| 2023 Q1 | 200.8 Million USD | 24.43% |
| 2023 FY | 1.1 Billion USD | 190.7% |
| 2023 Q3 | 293.79 Million USD | 19.17% |
| 2023 Q4 | 264.41 Million USD | -10.0% |
| 2022 Q3 | 127.71 Million USD | 81.97% |
| 2022 Q4 | 161.37 Million USD | 26.35% |
| 2022 Q1 | 22.04 Million USD | -15.3% |
| 2022 Q2 | 70.18 Million USD | 218.44% |
| 2022 FY | 381.31 Million USD | 3086.52% |
| 2021 Q4 | 26.02 Million USD | 2936.41% |
| 2021 FY | -12.76 Million USD | 95.07% |
| 2021 Q1 | 158.15 Million EUR | 302.03% |
| 2021 Q2 | 312.24 Million USD | 97.43% |
| 2021 Q3 | 857 Thousand USD | -99.73% |
| 2020 Q4 | -78.28 Million USD | -24.07% |
| 2020 FY | -258.8 Million EUR | -118.13% |
| 2020 Q3 | -63.09 Million EUR | 0.0% |
| 2019 Q2 | 8.55 Million EUR | -79.09% |
| 2019 Q4 | -57.34 Million EUR | -846.06% |
| 2019 FY | -118.64 Million EUR | -582.83% |
| 2019 Q1 | 40.93 Million EUR | 2779.29% |
| 2019 Q3 | 7.68 Million EUR | -10.19% |
| 2018 FY | 24.57 Million EUR | -43.75% |
| 2018 Q2 | 13.84 Million EUR | 101.54% |
| 2018 Q4 | 1.42 Million EUR | -41.83% |
| 2018 Q3 | 2.44 Million EUR | -82.34% |
| 2018 Q1 | 6.86 Million EUR | -33.43% |
| 2017 FY | 43.68 Million EUR | 182.33% |
| 2017 Q4 | 10.31 Million EUR | 34.09% |
| 2017 Q3 | 7.69 Million EUR | -58.56% |
| 2017 Q2 | 18.56 Million EUR | 160.87% |
| 2017 Q1 | 7.11 Million EUR | 93.52% |
| 2016 Q1 | 2.51 Million EUR | 32.96% |
| 2016 FY | 15.47 Million EUR | 106.49% |
| 2016 Q4 | 3.67 Million EUR | -33.21% |
| 2016 Q3 | 5.5 Million EUR | 45.64% |
| 2016 Q2 | 3.77 Million EUR | 50.51% |
| 2015 Q1 | 1.31 Million EUR | -26.42% |
| 2015 FY | 7.49 Million EUR | 64.07% |
| 2015 Q4 | 1.88 Million EUR | -26.43% |
| 2015 Q3 | 2.56 Million EUR | 48.66% |
| 2015 Q2 | 1.72 Million EUR | 31.8% |
| 2014 Q2 | 308.66 Thousand EUR | -9.48% |
| 2014 FY | 4.56 Million EUR | 70.61% |
| 2014 Q4 | 1.78 Million EUR | -11.35% |
| 2014 Q3 | 2 Million EUR | 550.83% |
| 2014 Q1 | 341 Thousand EUR | -63.5% |
| 2013 Q3 | 1.67 Million EUR | 215.1% |
| 2013 Q2 | 530.61 Thousand EUR | 21.42% |
| 2013 Q1 | 437 Thousand EUR | 0.0% |
| 2013 FY | 2.67 Million EUR | 22.6% |
| 2013 Q4 | 934.37 Thousand EUR | -44.12% |
| 2012 FY | 2.18 Million EUR | 49.75% |
| 2011 FY | 1.45 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -820.1% |
| Jaguar Health, Inc. | 7.72 Million USD | -14251.126% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 167039.91% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 22169720.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 26.972% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -825.639% |
| ContextLogic Inc. | 59 Million USD | -1778.781% |
| MiMedx Group, Inc. | 266.84 Million USD | -315.406% |
| MEI Pharma, Inc. | 49.32 Million USD | -2147.209% |
| AlloVir, Inc. | -398 Thousand USD | 278612.814% |
| Novavax, Inc. | 639.93 Million USD | -73.217% |
| Aptorum Group Limited | -1.11 Million USD | 99543.163% |
| Ardelyx, Inc. | 106.66 Million USD | -939.256% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -360.457% |
| Psyence Biomedical Ltd. | -240.00 USD | 461867183.333% |
| Vaxcyte, Inc. | -75 Million USD | 1577.975% |
| Precigen, Inc. | 106 Thousand USD | -1045636.792% |
| Pharming Group N.V. | 220.1 Million USD | -403.617% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -215139.029% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -109759.366% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -909.803% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 711.043% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 214611.772% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 955.838% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 2545.628% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 5141.529% |
| Acelyrin, Inc. | -115 Thousand USD | 963996.522% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 194229.772% |
| Senti Biosciences, Inc. | -2.68 Million USD | 41414.983% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -27263.145% |
| AbCellera Biologics Inc. | 38.02 Million USD | -2815.137% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 23202.98% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -923634.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -3705.421% |
| Chimerix, Inc. | 324 Thousand USD | -342023.765% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -223384.073% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1351906.098% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 3656.51% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 225401.016% |
| Elevation Oncology, Inc. | -39 Thousand USD | 2842358.974% |
| Alkermes plc | 1.37 Billion USD | 19.364% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1816.03% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1816.03% |
| Agenus Inc. | 139.61 Million USD | -693.956% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -6586.861% |
| Dyadic International, Inc. | 922.95 Thousand USD | -120001.045% |
| ImmuCell Corporation | 4.39 Million USD | -25114.044% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -5163.193% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1144.525% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 634086.491% |
| Immix Biopharma, Inc. | -5468.00 USD | 20272247.037% |
| Incyte Corporation | 3.44 Billion USD | 67.783% |
| IO Biotech, Inc. | -756 Thousand USD | 146724.471% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 2466.577% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 8398.35% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 2508656.622% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1228.604% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 2015520.0% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -138114.589% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 210437.951% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -3672.011% |
| NextCure, Inc. | -3.68 Million USD | 30189.061% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -5720.937% |
| Onconetix, Inc. | -1.12 Million USD | 98442.39% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 3926.571% |
| Opthea Limited | 21.72 Thousand USD | -5103403.683% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1933744.42% |
| PureTech Health plc | -1.6 Million USD | 69250.405% |
| Pyxis Oncology, Inc. | -2 Million USD | 55524.05% |
| Seer, Inc. | 7.02 Million USD | -15674.598% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 11028664.322% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -13983.103% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 28219.419% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -261334.198% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -964.833% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -719.464% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1243.353% |
| ChromaDex Corporation | 50.78 Million USD | -2082.909% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 477893.534% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1528.492% |
| CRISPR Therapeutics AG | 240.95 Million USD | -360.035% |
| Precision BioSciences, Inc. | 40.47 Million USD | -2638.884% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1229.225% |
| Innoviva, Inc. | 261.06 Million USD | -324.6% |
| Summit Therapeutics Inc. | -2.05 Million USD | 54172.244% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -25219.347% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -5044.957% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 935598.055% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 773633.332% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -181916.585% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -253.389% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -42964.53% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 2184729.484% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 15716.808% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 233688.174% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 10658571.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -1139011.714% |
| Century Therapeutics, Inc. | -10.8 Million USD | 10355.167% |
| Kura Oncology, Inc. | -849 Thousand USD | 130663.133% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1751.885% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 754168.707% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1019.237% |
| Autolus Therapeutics plc | -4.86 Million USD | 22875.447% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -2578.396% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 659910.119% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1070.234% |
| GRI Bio, Inc. | 10.84 Million USD | -10124.896% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -43541.225% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 12860.228% |
| IGM Biosciences, Inc. | -211.66 Million USD | 623.708% |
| INmune Bio, Inc. | 155 Thousand USD | -715049.032% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -1689.633% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 73690.096% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 171042.118% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 3786671.702% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -275641.542% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 55635.12% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 354247.284% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1073.48% |
| Verastem, Inc. | -62 Thousand USD | 1787972.581% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -45422.834% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 424805.364% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -36519.789% |
| Histogen Inc. | 3.76 Million USD | -29310.48% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -192284.832% |
| Surrozen, Inc. | -27.23 Million USD | 4170.808% |
| Organovo Holdings, Inc. | -5.38 Million USD | 20669.326% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 92099.286% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 4422.069% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -5428.032% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 55983988.889% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -18172.399% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1651320.747% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -616.115% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -760175.034% |
| Apollomics, Inc. | 127 Thousand USD | -872719.685% |
| Amarin Corporation plc | 165.54 Million USD | -569.611% |
| Mesoblast Limited | -9.81 Million USD | 11393.744% |
| Turnstone Biologics Corp. | 16.5 Million USD | -6615.625% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1103.25% |
| Synaptogenix, Inc. | -6347.00 USD | 17464744.714% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 2173592.157% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -586.94% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 36.934% |
| Better Therapeutics, Inc. | -2.72 Million USD | 40718.578% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1088.295% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -227.874% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9716798.808% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 17807.364% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 100143.412% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -15047.32% |
| Insmed Incorporated | 239.63 Million USD | -362.571% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -30880.464% |
| OmniAb, Inc. | 14.66 Million USD | -7457.653% |
| Alector, Inc. | -95.05 Million USD | 1266.172% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -782.401% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 2650.401% |
| Zai Lab Limited | 170.9 Million USD | -548.602% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1253.837% |
| Aura Biosciences, Inc. | -1.29 Million USD | 85696.988% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -852577.692% |
| Immunic, Inc. | -111 Thousand USD | 998731.532% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -6891.806% |
| Veracyte, Inc. | 248.14 Million USD | -346.702% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 115.86% |
| FibroGen, Inc. | 128.9 Million USD | -759.928% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 196539284.397% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 9601.088% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 67.384% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -284856.555% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -211.945% |
| TG Therapeutics, Inc. | 219.1 Million USD | -405.906% |
| Galecto, Inc. | -830 Thousand USD | 133651.928% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 80134.729% |
| Fortrea Holdings Inc. | 424 Million USD | -161.434% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1386.433% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 195599.295% |
| XBiotech Inc. | -1.74 Million USD | 63659.69% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 100143.412% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 2485.318% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1567.526% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1410.13% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -6496.923% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -184.927% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 2332.725% |
| Vaxxinity, Inc. | -2.23 Million USD | 49718.666% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -239.243% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 9888.913% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -4433.479% |
| NexImmune, Inc. | -1.02 Million USD | 108247.442% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -20527325.926% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 15699.981% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 90.192% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1658832.249% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 31316.024% |
| Ainos, Inc. | -253.73 Thousand USD | 436969.071% |
| Pluri Inc. | 322 Thousand USD | -344148.758% |
| Prothena Corporation plc | -129.2 Million USD | 957.951% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -2098.323% |
| Celularity Inc. | 6.75 Million USD | -16309.785% |
| Rallybio Corporation | -150 Thousand USD | 739087.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 3499.519% |
| MeiraGTx Holdings plc | 287 Thousand USD | -386130.314% |
| Omeros Corporation | -69.77 Million USD | 1688.56% |
| Humacyte, Inc. | -76.55 Million USD | 1548.048% |
| Immunocore Holdings plc | 248.39 Million USD | -346.265% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 7407.542% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -1676.924% |
| Blueprint Medicines Corporation | 236.58 Million USD | -368.536% |
| CalciMedica, Inc. | -58 Thousand USD | 1911274.138% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 77833.59% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -3715.113% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 39076.125% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 3691.385% |
| Pulmatrix, Inc. | -8.22 Million USD | 13585.17% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 94841.966% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 277914.787% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 377.958% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -39836.842% |
| Cytokinetics, Incorporated | -322.59 Million USD | 443.616% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -128478.421% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 325167.742% |
| Vor Biopharma Inc. | -3.49 Million USD | 31843.442% |
| Roivant Sciences Ltd. | 109.23 Million USD | -914.767% |
| Evogene Ltd. | 1.39 Million USD | -79133.81% |
| ProKidney Corp. | -3.16 Million USD | 35078.889% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 2624.324% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -16065.685% |
| CorMedix Inc. | -205.56 Thousand USD | 539344.121% |
| BioLineRx Ltd. | 1.1 Million USD | -99943.412% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 1509.008% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 3359133.333% |
| Atai Life Sciences N.V. | -5000.00 USD | 22169720.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 909742.292% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1154767.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 79904.248% |
| Sagimet Biosciences Inc. | 2 Million USD | -55324.05% |
| MediciNova, Inc. | 979.7 Thousand USD | -113044.365% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1414.628% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1172413.468% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5449.614% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -353.302% |
| Biomea Fusion, Inc. | -4.2 Million USD | 26486.122% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -27.07% |
| Mereo BioPharma Group plc | 7.42 Million USD | -14827.027% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 357674.516% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 9237441.667% |
| Absci Corporation | -41.84 Million USD | 2748.763% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 22169720.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 1551.404% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 45141.894% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -418.624% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 117898.193% |
| Allakos Inc. | -6.14 Million USD | 18150.497% |
| Imunon, Inc. | -720 Thousand USD | 154054.625% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1706.587% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -132.926% |
| BioAtla, Inc. | -103.73 Million USD | 1168.611% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 9716798.808% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 622842.135% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 556.505% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 356524.759% |
| XOMA Corporation | 3.86 Million USD | -28609.687% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1681.624% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -7392.774% |
| aTyr Pharma, Inc. | -2.38 Million USD | 46518.802% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -8796.316% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 3822448.276% |
| Viridian Therapeutics, Inc. | -1 Million USD | 110068.353% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -8526776823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 27712125.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -74.045% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -569204.292% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1411.18% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 4252.547% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -9547539.966% |
| Orgenesis Inc. | -5.72 Million USD | 19462.114% |
| Entera Bio Ltd. | -56 Thousand USD | 1979530.357% |
| GH Research PLC | -315 Thousand USD | 351998.73% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 586597.884% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 211239.238% |
| Xencor, Inc. | -85.26 Million USD | 1400.118% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 501727.319% |
| Replimune Group, Inc. | -2.65 Million USD | 41850.697% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 110811.261% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -523.288% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -569204.292% |
| Portage Biotech Inc. | -54 Thousand USD | 2052842.593% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1172413.468% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 294126.79% |
| OncoCyte Corporation | 413 Thousand USD | -268297.337% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 24660411.457% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 499315865.766% |
| Purple Biotech Ltd. | -196 Thousand USD | 565651.531% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -12260.404% |
| scPharmaceuticals Inc. | 9.78 Million USD | -11231.844% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 10712.595% |
| HilleVax, Inc. | -2.15 Million USD | 51513.776% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1142863.918% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 7388003.226% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 166040.269% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 4819582.609% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 14767717.53% |
| Savara Inc. | -44.26 Million USD | 2604.363% |
| Curis, Inc. | 9.81 Million USD | -11198.349% |
| Daré Bioscience, Inc. | 2.76 Million USD | -39924.271% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 888391.342% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 64211.105% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 486275.877% |
| BeiGene, Ltd. | 2.07 Billion USD | 46.678% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 39746.661% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 377.353% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1855.407% |
| Erasca, Inc. | -3.73 Million USD | 29802.063% |
| bluebird bio, Inc. | -4.03 Million USD | 27605.732% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3928376.278% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 41.793% |
| DBV Technologies S.A. | 15.72 Million USD | -6947.819% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 3928376.278% |
| Moderna, Inc. | 2.15 Billion USD | 48.562% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 121245.464% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -13745.628% |
| Molecular Templates, Inc. | 50.39 Million USD | -2099.585% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 206906.157% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -728.535% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 17915.509% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 2917.48% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1097.481% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 30994.119% |
| MacroGenics, Inc. | 50.52 Million USD | -2093.839% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 18277.78% |
| Prime Medicine, Inc. | -147.9 Million USD | 849.455% |
| Aditxt, Inc. | -111.66 Thousand USD | 992828.82% |
| Adagene Inc. | 18.11 Million USD | -6020.319% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -227047.746% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -690.631% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -602.299% |
| SciSparc Ltd. | 2.19 Million USD | -50377.277% |
| Vericel Corporation | 135.57 Million USD | -717.609% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4425350.509% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 3577922.607% |
| Generation Bio Co. | -73.91 Million USD | 1599.751% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 253756.979% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1929.479% |
| Invivyd, Inc. | -2.02 Million USD | 54758.826% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 468.461% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1071738.083% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1050.258% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1027.789% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1156.525% |
| Clene Inc. | 533 Thousand USD | -207870.169% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -4497.754% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 115928.736% |
| GeoVax Labs, Inc. | -20.72 Million USD | 5449.614% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -55658.602% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 570552.768% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -2125.642% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 15730.02% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 132693.421% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -1228.875% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1516040.989% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1985.1% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 740.045% |
| Trevena, Inc. | 1.45 Million USD | -76084.261% |
| Surrozen, Inc. | -27.23 Million USD | 4170.808% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 314117.28% |
| Cingulate Inc. | -582.91 Thousand USD | 190260.709% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 3575845.161% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 5727.093% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 14643177.939% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 125920.772% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -62.843% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 112294.433% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1967515.072% |
| Kronos Bio, Inc. | 1.37 Million USD | -80693.076% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 2165.518% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 379716.781% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 227101.683% |
| ImmunityBio, Inc. | -17.89 Million USD | 6296.093% |
| Korro Bio, Inc. | -3.63 Million USD | 30636.667% |
| Kineta, Inc. | 5.43 Million USD | -20302.742% |
| BioVie Inc. | -229.37 Thousand USD | 483357.258% |
| Codexis, Inc. | 57.33 Million USD | -1833.375% |
| Celularity Inc. | 6.75 Million USD | -16309.785% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -27522.253% |
| Celcuity Inc. | -142.77 Thousand USD | 776499.434% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -2191006.938% |
| Cibus, Inc. | 1.42 Million USD | -77852.25% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 296485.294% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 4936.516% |
| IN8bio, Inc. | -2.5 Million USD | 44421.511% |
| Kodiak Sciences Inc. | -25.94 Million USD | 4372.097% |
| Annexon, Inc. | -3.26 Million USD | 34029.63% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 54330.969% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 2755.871% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -173100.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -42.384% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -540.907% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 58441.105% |
| Arcellx, Inc. | 108.27 Million USD | -923.727% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 3524.514% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1299.527% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 5340.549% |
| Moolec Science SA | -143.3 Thousand USD | 773611.741% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 2719.408% |
| Geron Corporation | -123.5 Million USD | 997.534% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -33623.182% |
| Royalty Pharma plc | 1.79 Billion USD | 38.208% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1681.511% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 30688942.746% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -478951.043% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1094.921% |
| Humacyte, Inc. | -76.55 Million USD | 1548.048% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 116883.751% |
| 89bio, Inc. | -273 Thousand USD | 406136.996% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 88284.646% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 130817.099% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 901304.065% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -98959.964% |
| Notable Labs, Ltd. | 113 Thousand USD | -980856.637% |
| Liquidia Corporation | 14.6 Million USD | -7492.336% |
| Mustang Bio, Inc. | -2.22 Million USD | 49919.371% |
| Immunovant, Inc. | -231 Thousand USD | 479961.905% |
| Quantum-Si incorporated | 488 Thousand USD | -227047.746% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 2095.142% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 3695036.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -59431.74% |
| Acasti Pharma Inc. | -11 Thousand USD | 10077200.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 541834.558% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 171042.118% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 761.732% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -97599.677% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 291039.895% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 56712.921% |
| PepGen Inc. | -1.18 Million USD | 93721.706% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 872919.685% |
| United Therapeutics Corporation | 2.07 Billion USD | 46.45% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 4941.163% |
| Solid Biosciences Inc. | -76.56 Million USD | 1547.802% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1342362.935% |
| Immuneering Corporation | -764.13 Thousand USD | 145162.934% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1672725.365% |
| Belite Bio, Inc | -399 Thousand USD | 277914.787% |
| XOMA Corporation | 3.86 Million USD | -28609.687% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 5632.447% |
| Bionomics Limited | -434.44 Thousand USD | 255246.404% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 103310.521% |
| uniQure N.V. | 2.21 Million USD | -49944.289% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1339.593% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1303.968% |
| Forte Biosciences, Inc. | -9000.00 USD | 12316555.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 132852.216% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 253756.979% |
| Altimmune, Inc. | -65.37 Million USD | 1795.625% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -206.185% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 103310.521% |
| Compugen Ltd. | 31.45 Million USD | -3424.022% |
| Peak Bio, Inc. | 367.76 Thousand USD | -301306.861% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -4421.459% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1026271.296% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1421229.487% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 92243.059% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 60938.694% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 931596.639% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 92243.059% |
| Instil Bio, Inc. | -4.75 Million USD | 23407.002% |
| Immunome, Inc. | -8.9 Million USD | 12545.054% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 58749.788% |
| Verona Pharma plc | -679.62 Thousand USD | 163202.098% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 633517.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 46577.191% |
| CervoMed Inc. | -1.29 Million USD | 85787.837% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 46152.389% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 23304.543% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -44759.611% |
| Moolec Science SA | -143.3 Thousand USD | 773611.741% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 271766.544% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 41592.397% |
| AnaptysBio, Inc. | 14.78 Million USD | -7399.364% |
| Design Therapeutics, Inc. | -537 Thousand USD | 206521.043% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 259697.424% |
| NeurAxis, Inc. | 2.15 Million USD | -51296.993% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -51553.355% |
| Lumos Pharma, Inc. | 2 Million USD | -55130.742% |
| Achilles Therapeutics plc | -4.73 Million USD | 23528.841% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 633517.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1049052.922% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -3401.341% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -128478.421% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 107510.95% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 2533.655% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -2577762.791% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 134951.703% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 8424488.205% |
| Palisade Bio, Inc. | 246 Thousand USD | -450502.033% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 3359133.333% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1957.623% |
| Neurogene Inc. | -3.26 Million USD | 34081.637% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -695.551% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 30123.862% |
| Sesen Bio, Inc. | 40 Million USD | -2671.203% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 373325.926% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 27625.97% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 11687.717% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -7772.734% |
| Athira Pharma, Inc. | -969 Thousand USD | 114494.324% |
| Vaccinex, Inc. | -16 Million USD | 7026.275% |
| HCW Biologics Inc. | -574.82 Thousand USD | 192938.33% |
| XOMA Corporation | 3.86 Million USD | -28609.687% |
| Nektar Therapeutics | 53.47 Million USD | -1972.779% |
| Arvinas, Inc. | 71.8 Million USD | -1443.845% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1428.142% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1865.8% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 344348.758% |
| Rezolute, Inc. | -36 Thousand USD | 3079213.889% |
| Clene Inc. | 533 Thousand USD | -207870.169% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 86330395.95% |
| BeyondSpring Inc. | 1.75 Million USD | -63205.597% |
| Synlogic, Inc. | -1.92 Million USD | 57713.358% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 2995994.595% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 17606.017% |
| Peak Bio, Inc. | 367.76 Thousand USD | -301306.861% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 5945.494% |
| Krystal Biotech, Inc. | 47.6 Million USD | -2228.497% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -685.65% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -21959.323% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 42911.404% |
| MannKind Corporation | 136.19 Million USD | -713.916% |
| Ikena Oncology, Inc. | -50.49 Million USD | 2295.36% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -918.693% |
| Gossamer Bio, Inc. | -4.38 Million USD | 25378.928% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 439973.413% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 22169720.0% |
| Legend Biotech Corporation | 140.92 Million USD | -686.553% |
| Mural Oncology plc | -2.56 Million USD | 43281.963% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 201276.225% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1108581.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -5241.048% |
| REGENXBIO Inc. | 53.02 Million USD | -1990.33% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 20792.379% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 576308.447% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 64100.058% |
| Vaxart, Inc. | -60.76 Million USD | 1924.27% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 421928.526% |
| Cellectis S.A. | 18 Thousand USD | -6158127.778% |
| Longeveron Inc. | 221 Thousand USD | -501475.113% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1484.39% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -1.417% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 85763.138% |
| Revolution Medicines, Inc. | -399.66 Million USD | 377.353% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 3167188.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -2262106.122% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 87.121% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1287.51% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 4425350.509% |
| Veru Inc. | 7.56 Million USD | -14550.959% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 734193.377% |
| Cingulate Inc. | -582.91 Thousand USD | 190260.709% |
| Passage Bio, Inc. | -3.72 Million USD | 29889.868% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 9203695.151% |
| Exicure, Inc. | -1.42 Million USD | 77997.47% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 289520.627% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -40909.286% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 216315.146% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -1527.104% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 741028.566% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1972.244% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -283398.977% |
| OmniAb, Inc. | 14.66 Million USD | -7457.653% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -5444.346% |
| Lipocine Inc. | -2.85 Million USD | 38982.91% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 60245.469% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 19529.991% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 73690.096% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1371.774% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1705455.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1214.986% |
| Ocugen, Inc. | -33.53 Million USD | 3405.248% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 35156.325% |
| Q32 Bio Inc. | 578 Thousand USD | -191678.72% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 418394.717% |
| Alumis Inc. Common Stock | -1.28 Million USD | 86430.296% |
| Equillium, Inc. | 35.95 Million USD | -2982.71% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 65037.376% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -221295.545% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 26813863.909% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 428084.942% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -262130.786% |
| Dominari Holdings Inc. | 2.03 Million USD | -54263.953% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 604272.322% |
| vTv Therapeutics Inc. | -13.59 Million USD | 8253.593% |
| Bio-Techne Corporation | 773.07 Million USD | -43.386% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -6300.375% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -140.563% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 94923.011% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 4722.523% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -9376.626% |
| Nkarta, Inc. | -5.86 Million USD | 18987.051% |
| BioCardia, Inc. | -7.24 Million USD | 15391.502% |
| Iterum Therapeutics plc | -1.75 Million USD | 63441.771% |